NCT01530841View on ClinicalTrials.gov

Efficacy and Tolerance of AVAPS Mode in Myotonic Dystrophy

NACompletedINTERVENTIONAL

Enrollment

32

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions

Myopathy

Interventions

DEVICE

Nocturnal ventilation

Home ventilation only the mode AVAPS will be used if the patient is randomized in the experimental group.

Trial Locations (1)

92380

Home ventilation Unit , Raymond Poincaré hospital, Garches

Sponsors

Collaborators (1)

Philips Respironics

All Listed Sponsors

collaborator

Adep Assistance

OTHER

collaborator

Philips Respironics

INDUSTRY

lead

Centre d'Investigation Clinique et Technologique 805

OTHER

NCT01530841 - Efficacy and Tolerance of AVAPS Mode in Myotonic Dystrophy | Biotech Hunter | Biotech Hunter